GlassScriptPhysician profile
Samir Naser Shahen
NPI 1558773663
$585.47
in general payments reported to CMS, 2019-2025
12 companies · $30.05 in 2025
The $30.05 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $13.48 · 2021: $90.40 · 2022: $95.79 · 2023: $79.58 · 2024: $25.63 · 2025: $30.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $124.01 | 2019 | |
| Glaxosmithkline, LLC. | $99.39 | 2022-2023 | Bexsero, Pediarix, Shingrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.40 | 2021 | |
| Vapotherm INC | $84.60 | 2019 | |
| Exact Sciences Corporation | $30.05 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $27.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.05 | 2019-2020 | |
| Penumbra, INC. | $25.63 | 2024 | Indigo System |
| Abbott Laboratories | $24.91 | 2022 | |
| Renalytix Ai, INC. | $23.64 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Novartis Pharmaceuticals Corporation | $15.57 | 2019 | |
| Genentech USA, INC. | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Shahen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.